The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of nivolumab in patients with high-risk biochemically recurrent (BCR) prostate cancer (PCa).
 
David Johnson Einstein
Research Funding - Bristol-Myers Squibb (Inst); Oncbiomune LLC (Inst); Trovagene (Inst)
 
Xiao X. Wei
Honoraria - OncLive
Travel, Accommodations, Expenses - Corvus Pharmaceuticals
 
Lillian Werner
No Relationships to Disclose
 
Huihui Ye
Consulting or Advisory Role - Janssen
 
Carla Calagua
No Relationships to Disclose
 
Glenn Bubley
No Relationships to Disclose
 
Steven P. Balk
Honoraria - Janssen
Consulting or Advisory Role - Sanofi
Patents, Royalties, Other Intellectual Property - License to NKT Therapeutics for an antibody
Expert Testimony - Astellas Medivation
Travel, Accommodations, Expenses - Janssen